Through improvements in radiopharmaceuticals and instrumentation, nuclear medicine continues to develop and refine in-vivo approaches for diagnosis (including staging and prognosis) and treatment of disease.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1 Department of Nuclear Medicine and Cardiology, St Andrew's War Memorial Hospital, Brisbane, QLD.
- 2 Department of Nuclear Medicine, St George's Hospital, Sydney, NSW.
Correspondence: fkhafagi@bigpond.com
- 1. Scott AM. Current status of positron emission tomography in oncology. Intern Med J 2001; 31: 27-36.
- 2. Knott JC, Better N. Myocardial perfusion imaging in the evaluation of undiagnosed acute chest pain. Intern Med J 2001; 31: 544-546.
- 3. Uren RF, Thompson JF, Howman-Giles R. Sentinel lymph node biopsy in patients with melanoma and breast cancer. Intern Med J 2001; 31: 547-553.
- 4. Tu SM, Millikan RE, Mengistu B, et al. Bone-targeted therapy for advanced androgen-independent carcinoma for the prostate: a randomised phase II trial. Lancet 2001; 357: 336-341.
- 5. Press OW, Eary JF, Gooley T, et al. A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide and autologous stem cell transplantation for relapsed B-cell lymphomas. Blood 2000; 96: 2934-2942.
Online responses are no longer available. Please refer to our instructions for authors page for more information.